Insulin Resistance, Hyperinsulinemia, and Renal Injury: Mechanisms and Implications

2006 ◽  
Vol 26 (3) ◽  
pp. 232-244 ◽  
Author(s):  
Pantelis A. Sarafidis ◽  
Luis M. Ruilope
2007 ◽  
Vol 177 (4S) ◽  
pp. 37-37
Author(s):  
James K. Kuan ◽  
Robert Kaufman ◽  
Jonathan L. Wright ◽  
Charles Mock ◽  
Avery B. Nathens ◽  
...  

Hypertension ◽  
1996 ◽  
Vol 28 (1) ◽  
pp. 127-132 ◽  
Author(s):  
Donald R. Dengel ◽  
Andrew P. Goldberg ◽  
Ronaldo S. Mayuga ◽  
Gretchen M. Kairis ◽  
Matthew R. Weir

PLoS ONE ◽  
2013 ◽  
Vol 8 (4) ◽  
pp. e62068 ◽  
Author(s):  
Jung Eun Kim ◽  
Mi Hwa Lee ◽  
Deok Hwa Nam ◽  
Hye Kyoung Song ◽  
Young Sun Kang ◽  
...  

2011 ◽  
Vol 301 (3) ◽  
pp. F580-F587 ◽  
Author(s):  
C. Fanelli ◽  
B. H. V. Fernandes ◽  
F. G. Machado ◽  
C. Okabe ◽  
D. M. A. C. Malheiros ◽  
...  

We recently standardized a model (LLact) of severe chronic kidney disease based on impaired nephrogenesis by suppression of angiotensin II activity during lactation (Machado FG, Poppi EP, Fanelli C, Malheiros DM, Zatz R, Fujihara CK. Am J Physiol Renal Physiol 294: F1345–F1353, 2008). In this new study of the LLact model, we sought to gain further insight into renal injury mechanisms associated with this model and to verify whether the renoprotection obtained with the association of the angiotensin II receptor blocker losartan (L) and hydrochlorothiazide (H), which arrested renal injury in the remnant kidney model, would provide similar renoprotection. Twenty Munich-Wistar dams, each nursing six pups, were divided into control, untreated, and LLact groups, given losartan (L; 250 mg·kg−1·day−1) until weaning. The male LLact offspring remained untreated until 7 mo of age, when renal functional and structural parameters were studied in 17 of them, used as pretreatment control (LLactPre), and followed no further. The remaining rats were then divided among groups LLact+V, untreated; LLact+L, given L (50 mg·kg−1·day−1) now as a therapy; LLact+H, given H (6 mg·kg−1·day−1); and LLact+LH, given L and H. All parameters were reassessed 3 mo later in these groups and in age-matched controls. At this time, LLact rats exhibited hypertension, severe albuminuria, glomerular damage, marked interstitial expansion/inflammation, enhanced cell proliferation, myofibroblast infiltration, and creatinine retention. L monotherapy normalized albuminuria and prevented hypertension and the progression of renal injury, inflammation, and myofibroblast infiltration. In contrast to the remnant model, the LH combination promoted only slight additional renoprotection, perhaps because of a limited tendency to retain sodium in LLact rats.


2008 ◽  
Vol 39 (4) ◽  
pp. 380-387 ◽  
Author(s):  
Huang Chang-Quan ◽  
Dong Bi-Rong ◽  
He Ping ◽  
Lu Zhen-Chan ◽  
Peng Xiao-Dong

1998 ◽  
Vol 2 (4) ◽  
pp. 276-281 ◽  
Author(s):  
Seiichi Matsuo ◽  
Yoshiki Morita ◽  
Masashi Mizuno ◽  
Kazuhiro Nishikawa ◽  
Yukio Yuzawa

2013 ◽  
Vol 84 (2) ◽  
pp. 265-276 ◽  
Author(s):  
Pengchao Du ◽  
Baoxia Fan ◽  
Huirong Han ◽  
Junhui Zhen ◽  
Jin Shang ◽  
...  

2008 ◽  
Vol 56 (6) ◽  
pp. 872-877
Author(s):  
Huang Chang-Quan ◽  
Dong Bi-Rong ◽  
Xiao Qian ◽  
He Ping ◽  
Ding Qun-Fang ◽  
...  

ObjectiveThe study aimed to explore the relationship among renal injury, abnormal vitamin D metabolism, and bone homeostasis in insulin resistance (IR) or type 2 diabetes mellitus (T2DM).Design and MethodsThe animal models of IR, T2DM, and T2DM treated with 1-alpha hydroxyvitamin D (1-α(OH)D) were established on 18-month-old male Wistar rats. Glucose infusion rates (GIR) and levels of urinary albumin (UA), serum 25-hydroxyvitamin D (25-(OH)D), serum 1,25-dihydroxyvitamin D (1,25-(OH)2D), and bone mineral density (BMD) in lumbar vertebrae and femoral bone were measured.ResultsUrinary albumin level in the rats with T2DM significantly increased, and there existed a significant and negative correlation between GIR and UA level in the rats with T2DM or IR. The levels of serum 25-(OH)D in all models were similar. The levels of serum 1,25-(OH)2D and BMD in the rats with IR were significantly higher than those in the rats with T2DM and were lower than those in normal control rats. In the aged rats with T2DM, administration of 1-α(OH)D had no effect on serum 25-(OH)D level although significantly increased the levels of serum 1,25-(OH)2D and BMD. There existed a negative correlation between the levels of serum 1,25-(OH)2D and UA in the rats with T2DM or IR.ConclusionsIn IR or T2DM, abnormal vitamin D metabolism is characterized by 1,25-(OH)2D deficiency and is related to renal injury, and there also existed bone loss. In T2DM, both 1,25-(OH)2D deficiency and bone loss can be reversed by 1-α(OH)D.


Sign in / Sign up

Export Citation Format

Share Document